A trial of selenium and vitamin E in boys with muscular dystrophy
- PMID: 3298399
- DOI: 10.1177/088307388600100306
A trial of selenium and vitamin E in boys with muscular dystrophy
Abstract
The administration of selenium and vitamin E was tried in a group of 20 boys with muscular dystrophy. Muscular strength was measured at intervals of 6 months. The boys were treated for 1 year (selenium 6 micrograms/kg for 6 months and 20 micrograms/kg for 6 months), followed by 1 year of no treatment. The whole series was completed in 16 boys, nine of whom had classical Duchenne muscular dystrophy and the rest who had more benign variants. No boy showed any side effects. The decrease of muscle strength was slightly more rapid during the second year (no treatment) than during the first year (with treatment) of the trial. The difference was, however, slight and could conceivably be explained by the increase of age. No boy showed any practically usable increase of muscle strength during the year of treatment. The minimal muscle strength required for walking is presented.
Similar articles
-
Selenium and vitamin E treatment of Duchenne muscular dystrophy: no effect on muscle function.Acta Neurol Scand. 1988 Nov;78(5):429-35. doi: 10.1111/j.1600-0404.1988.tb03681.x. Acta Neurol Scand. 1988. PMID: 3218450
-
Systolic time intervals in patients with progressive muscular dystrophy treated with sodium selenite and vitamin E.Med Biol. 1984;62(2):154. Med Biol. 1984. PMID: 6471936 No abstract available.
-
Clinical investigation in Duchenne muscular dystrophy: penicillamine and vitamin E.Muscle Nerve. 1988 Nov;11(11):1164-8. doi: 10.1002/mus.880111110. Muscle Nerve. 1988. PMID: 3067086 Clinical Trial.
-
Steroids in muscular dystrophy: where do we stand?Neuromuscul Disord. 1998 Aug;8(6):380-4. doi: 10.1016/s0960-8966(98)00047-9. Neuromuscul Disord. 1998. PMID: 9713854 Review. No abstract available.
-
Prednisone in Duchenne dystrophy.Neuromuscul Disord. 1991;1(3):161-3. doi: 10.1016/0960-8966(91)90019-o. Neuromuscul Disord. 1991. PMID: 1822789 Review. No abstract available.
Cited by
-
Pharmacologic management of Duchenne muscular dystrophy: target identification and preclinical trials.ILAR J. 2014;55(1):119-49. doi: 10.1093/ilar/ilu011. ILAR J. 2014. PMID: 24936034 Free PMC article. Review.
-
Increased catalase expression improves muscle function in mdx mice.Exp Physiol. 2011 Feb;96(2):194-202. doi: 10.1113/expphysiol.2010.054379. Epub 2010 Nov 1. Exp Physiol. 2011. PMID: 21041317 Free PMC article.
-
Duchenne Muscular Dystrophy.Curr Treat Options Neurol. 2001 Mar;3(2):105-117. doi: 10.1007/s11940-001-0045-2. Curr Treat Options Neurol. 2001. PMID: 11180747
-
Absence of Dystrophin Disrupts Skeletal Muscle Signaling: Roles of Ca2+, Reactive Oxygen Species, and Nitric Oxide in the Development of Muscular Dystrophy.Physiol Rev. 2016 Jan;96(1):253-305. doi: 10.1152/physrev.00007.2015. Physiol Rev. 2016. PMID: 26676145 Free PMC article. Review.
-
Effects of selenium and vitamin E on muscular strength and blood parameters in Steinert disease.Ital J Neurol Sci. 1990 Feb;11(1):37-42. doi: 10.1007/BF02334903. Ital J Neurol Sci. 1990. PMID: 2332324
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical